Lupus or to use its full name, systemic lupus erythematosus (SLE) – try saying that after a few beers, is a nasty auto-immune disease. Sally Church on Pharma Strategy Blog discusses three recent research papers from Science Translational Medicine that provide new insight on the biology of this disease.
Sally asks, “can we improve treatment of lupus by understanding the biology better?”
Her review of the papers suggests that knowledge of the underlying biology of the disease may help develop new strategies for treating SLE. You can read Sally’s thoughtful post about the science and new products in development for Lupus on Pharma Strategy Blog.